| Pack Size/Qty | Price | Unit Price | |
| 90 Tablet/s | $35.00 | $0.40 | |
| 60 Tablet/s | $27.00 | $0.45 | |
| 30 Tablet/s | $15.00 | $0.50 |
Generic Name : Glimepiride 0.5mg + Metformin 500mg
Brand Name : Glimepiride 0.5mg + Metformin 500mg
Manufacturer Name : US Vitamin
Product Code : CRX 230
Delivery Days : 10 to 15 working days
Packaging : Tablet/s (Blister Packing)
Prescribed For : Type 2 Diabetes Mellitus, Control High Blood Pressure, Prevent Kidney Damage
Glycomet-GP 0.5 Tablet SR is a medication that belongs to the class of antidiabetic drugs. It is specifically formulated to manage diabetes mellitus, a chronic metabolic disorder characterized by elevated levels of blood glucose. This medication is commonly prescribed to individuals who have type 2 diabetes, a condition where the body either does not produce enough insulin or does not utilize insulin effectively.
The primary active ingredients in Glycomet-GP 0.5 Tablet SR are Metformin and Glimepiride. Let's delve into the details of each component and understand how they contribute to the efficacy of this medication.
Metformin is an oral antidiabetic drug that falls into the category of biguanides. It is considered a first-line treatment for type 2 diabetes due to its effectiveness and safety profile. Metformin works by improving the sensitivity of body tissues to insulin, the hormone responsible for regulating blood sugar levels. Additionally, it reduces the production of glucose in the liver, thereby lowering overall blood glucose levels.
Metformin also has beneficial effects on lipid metabolism, helping to reduce levels of triglycerides and low-density lipoprotein (LDL or "bad" cholesterol). These secondary effects make Metformin a valuable component in the management of cardiovascular risk factors associated with diabetes.
Glimepiride is a sulfonylurea antidiabetic medication that stimulates the release of insulin from the pancreas. It works by increasing the secretion of insulin from the beta cells of the pancreas, which helps lower blood sugar levels. Glimepiride is particularly useful when the body's natural insulin production is insufficient to meet the demands created by the presence of elevated blood glucose.
The combination of Metformin and Glimepiride in Glycomet-GP 0.5 Tablet SR addresses multiple aspects of diabetes management. Metformin improves insulin sensitivity and reduces hepatic glucose production, while Glimepiride enhances insulin secretion, resulting in better control over blood sugar levels throughout the day.
Glycomet-GP 0.5 Tablet SR is a sustained-release formulation. This means that the medication is released slowly and continuously into the bloodstream over an extended period, allowing for once-daily dosing. The sustained-release feature helps maintain a more consistent level of the drug in the body, optimizing its therapeutic effects.
The typical dosage of Glycomet-GP 0.5 Tablet SR is determined by a healthcare professional based on individual patient factors, including the severity of diabetes, response to treatment, and other medical conditions. It is crucial for patients to adhere to the prescribed dosage and schedule to achieve optimal therapeutic outcomes.
As with any medication, Glycomet-GP 0.5 Tablet SR is not without potential side effects. Common side effects may include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. These side effects are often temporary and may improve as the body adjusts to the medication.
Patients with a history of kidney or liver dysfunction should exercise caution, as Metformin is primarily excreted through the kidneys. Regular monitoring of kidney function is typically recommended during treatment.
Hypoglycemia (low blood sugar) is a potential side effect of Glimepiride. This risk is heightened in elderly patients, those with impaired kidney or liver function, and individuals with irregular meal patterns. It is important for patients to be aware of the signs of hypoglycemia, such as dizziness, sweating, and confusion, and to take appropriate measures to address low blood sugar levels.
Patients taking Glycomet-GP 0.5 Tablet SR should inform their healthcare provider about all other medications, including over-the-counter drugs and herbal supplements, to avoid potential interactions.
In summary, Glycomet-GP 0.5 Tablet SR is a combination medication that plays a crucial role in the management of type 2 diabetes. By combining the complementary mechanisms of Metformin and Glimepiride, this medication helps improve insulin sensitivity, reduce hepatic glucose production, and enhance insulin secretion. The sustained-release formulation provides convenience with once-daily dosing and contributes to the overall effectiveness of the treatment.
As with any medication, it is essential for patients to work closely with their healthcare providers to ensure proper dosage, monitor for potential side effects, and make necessary adjustments to the treatment plan. With appropriate medical supervision and lifestyle modifications, Glycomet-GP 0.5 Tablet SR can be a valuable tool in achieving and maintaining optimal blood sugar control for individuals with type 2 diabetes.
